美国 · 交易所与实时行情 · Nasdaq
Cocrystal Pharma Posts Wider Q3 Loss, Led By Norovirus Challenge Study Costs
详细摘要
(RTTNews) - Cocrystal Pharma, Inc. (COCP), a clinical stage biotechnology firm, on Sunday reported a wider loss in its third quarter, driven by higher clinical trial and related…
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.nasdaq.com)


